Vision, Values, Combined Expertise
"Our mission is to help all patients get access to the right test they need to treat their condition or disease."
CMT's vision is to remove barriers and improve patient access to care involving diagnostic testing - through a sustainable solution that efficiently navigates the
complex landscape involving payors, physicians,
laboratories and the patient.
Meet the Team
Board of Directors
Dr. Smith possesses over thirty-five years of experience in healthcare management, pathology, laboratory medicine, outreach laboratory businesses, molecular diagnostics, and blood banking. He is a board-certified clinical and anatomic pathologist and transfusion medicine specialist. Dr. Smith’s professional career includes serving on the executive management team and Board of Directors of AmeriPath, Inc. (NASDAQ: PATH). While at AmeriPath, Dr. Smith’s positions included Chief Medical Officer, Executive Vice-President of Genomic Strategies, and Executive Director of AmeriPath’s Center for Advanced Diagnostics.
Previously, Dr. Smith has held board seats at Immucor, Inc. (NASDAQ: BLUD), Clarient, Inc. (NASDAQ:CLRT), the American Association of Blood Banks (President), the National Blood Foundation (Chairman), and RedPath Integrated Pathology, Inc., a venture-backed, early-stage molecular diagnostics company where he served as CEO and led a successful sale of the company to PDI, Inc. He is an Emeritus member of the Committee of Visitors for Vanderbilt University School of Engineering, from which he graduated summa cum laude.
Dr. Smith received his BS from Vanderbilt and his MD from the University of Tennessee.